VitaSpring Biomedical (VSBC) Financial Statements
VitaSpring Biomedical Financial Overview
VitaSpring Biomedical's market cap is currently $6.58M. The company's EPS TTM is $-0.00; its P/E ratio is -13.83; VitaSpring Biomedical has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jan 26 | Jan 25 | Jan 23 | Jan 22 | Jan 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 5.61M | $ 248.20K |
| Gross Profit | $ -9.96K | $ -9.96K | $ -219.34K | $ 2.07M | $ 112.20K |
| Operating Income | $ -385.41K | $ -679.91K | $ -4.18M | $ 1.48M | $ -425.38K |
| EBITDA | $ -375.45K | $ -669.96K | $ -4.15M | $ 1.49M | $ -424.26K |
| Net Income | $ -415.37K | $ -774.92K | $ -4.16M | $ 1.26M | $ -425.38K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.08K | $ 272.00 | $ 29.66K | $ 107.21K | $ 45.40K |
| Total Assets | $ 14.68K | $ 14.38K | $ 765.95K | $ 3.60M | $ 189.40K |
| Total Debt | $ 0.00 | $ 0.00 | $ 262.98K | $ 463.57K | $ 0.00 |
| Net Debt | $ -2.08K | $ -272.00 | $ 233.32K | $ 356.36K | $ -45.40K |
| Total Liabilities | $ 4.45M | $ 4.03M | $ 3.16M | $ 2.03M | $ 93.03K |
| Stockholders' Equity | $ -4.43M | $ -4.02M | $ -2.40M | $ 1.58M | $ 386.77K |
| Cash Flow | |||||
| Free Cash Flow | $ -2.69K | $ -14.68K | $ -77.56K | $ 11.81K | $ -42.13K |
| Operating Cash Flow | $ -2.69K | $ -14.68K | $ -77.56K | $ 84.81K | $ -42.13K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ -73.00K | $ 0.00 |
| Financing Cash Flow | $ 4.50K | $ 14.93K | $ 0.00 | $ 50.00K | $ 87.53K |
Currency in USD
